Amyloid beta-correlated plasma metabolite dysregulation in Alzheimer's disease: an untargeted metabolism exploration using high-resolution mass spectrometry toward future clinical diagnosis

INTRODUCTION: Alzheimer's disease (AD) is a leading cause of dementia, and it has rapidly become an increasingly burdensome and fatal disease in society. Despite medical research advances, accurate recognition of AD remains challenging. Epidemiological evidence suggests that metabolic abnormali...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingzhi, Wu, Shuo, Yang, Jun, Zhang, Qun, Dong, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338932/
https://www.ncbi.nlm.nih.gov/pubmed/37455936
http://dx.doi.org/10.3389/fnagi.2023.1189659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338932/
https://www.ncbi.nlm.nih.gov/pubmed/37455936
http://dx.doi.org/10.3389/fnagi.2023.1189659

Ejemplares similares